Literature DB >> 19833061

Minimal lymph node involvement and outcome of breast cancer. The results of the Dutch MIRROR study.

Vivianne C Tjan-Heijnen1, Maaike de Boer.   

Abstract

Even when a breast cancer patient has only minimal lymph node involvement, additional therapy is needed. If women are not treated with adjuvant systemic therapy like chemotherapy and/or hormonal therapy, disease-free survival is reduced by 10% at 5-year follow-up. These are the main results from the MIRROR study, a Dutch cohort study in which all hospitals from The Netherlands have participated. The results were recently published in the New England Journal of Medicine (de Boer, 2009). The study was supported by a grant from the Netherlands Organization for Health Research and Development (945-06-509).

Entities:  

Mesh：

Year:  2009        PMID： 19833061

Source DB:  PubMed          Journal:  Discov Med        ISSN： 1539-6509            Impact factor:   2.970


  6 in total

1.  Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter A: Surgery, Pathology and Prognostic Factors, Adjuvant and Neoadjuvant Therapy, Adjuvant Radiotherapy.

Authors:  Christoph Thomssena; Nadia Harbeckb
Journal:  Breast Care (Basel)       Date:  2010-08-20       Impact factor: 2.860

2.  Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.

Authors:  R Kreienberg; U-S Albert; M Follmann; I B Kopp; T Kühn; A Wöckel
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-06       Impact factor: 2.915

3.  Frozen section analysis of sentinel lymph nodes in patients with breast cancer does not impair the probability to detect lymph node metastases.

Authors:  Eva V E Madsen; Jan van Dalen; Joost van Gorp; Poultje M P van Oort; Thijs van Dalen
Journal:  Virchows Arch       Date:  2011-11-25       Impact factor: 4.064

4.  Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer?

Authors:  Armando E Giuliano; Monica Morrow; Shivani Duggal; Thomas B Julian
Journal:  Clin Exp Metastasis       Date:  2012-08-29       Impact factor: 5.150

5.  The Attitudes of Brazilian Breast Surgeons on Axillary Management in Early Breast Cancer-10 Years after the ACOSOG Z0011 Trial First Publication.

Authors:  Eduardo Camargo Millen; Francisco Pimentel Cavalcante; Felipe Zerwes; Guilherme Novita; Alessandra Borba Anton de Souza; João Henrique Penna Reis; Helio Rubens de Oliveira Filho; Luciana Naíra de B L Limongi; Barbara Pace Silva de Assis Carvalho; Adriana Magalhães de Oliveira Freitas; Monica Travassos Jourdan; Vilmar Marques de Oliveira; Ruffo Freitas-Junior
Journal:  Ann Surg Oncol       Date:  2021-09-27       Impact factor: 5.344

6.  Which patients need an axillary clearance after sentinel node biopsy?

Authors:  Anastasia Pazaiti; Ian S Fentiman
Journal:  Int J Breast Cancer       Date:  2011-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.